Tetraphase: La Jolla Pharmaceutical Company Announces the Closing of Acquisition of Tetraphase Pharmaceuticals, Inc. -Combined Company Offers Two Innovative Therapies to Treat Patients Suffering from Life-threatening Diseases-
La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases, and Tetraphase Pharmaceuticals, Inc.
Read full article »
Tetraphase is a biopharmaceutical company that develops and commercializes novel tetracyclines for bacterial infections and orphan diseases.
Read more